Amdocs Limited (NASDAQ:DOX) Given Average Recommendation of “Moderate Buy” by Analysts

Amdocs Limited (NASDAQ:DOXGet Free Report) has earned an average recommendation of “Moderate Buy” from the five analysts that are covering the stock, Marketbeat reports. Two analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $92.3333.

A number of research firms recently issued reports on DOX. Stifel Nicolaus lowered their target price on shares of Amdocs from $97.00 to $88.00 and set a “buy” rating on the stock in a research note on Wednesday, February 4th. Weiss Ratings reiterated a “hold (c)” rating on shares of Amdocs in a research note on Tuesday, January 27th. Wall Street Zen cut Amdocs from a “buy” rating to a “hold” rating in a research report on Saturday, March 21st. Finally, Barclays decreased their target price on Amdocs from $111.00 to $92.00 and set an “overweight” rating for the company in a research note on Wednesday, February 4th.

Get Our Latest Stock Report on Amdocs

Amdocs Stock Performance

DOX opened at $66.43 on Friday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.06 and a current ratio of 1.06. The company has a market cap of $7.17 billion, a PE ratio of 12.85, a price-to-earnings-growth ratio of 1.15 and a beta of 0.46. The stock has a 50-day moving average of $70.05 and a 200-day moving average of $77.27. Amdocs has a 52-week low of $63.33 and a 52-week high of $95.41.

Amdocs (NASDAQ:DOXGet Free Report) last issued its quarterly earnings data on Tuesday, February 3rd. The technology company reported $1.81 earnings per share for the quarter, beating analysts’ consensus estimates of $1.75 by $0.06. Amdocs had a return on equity of 20.19% and a net margin of 12.47%.The business had revenue of $1.16 billion for the quarter, compared to the consensus estimate of $1.15 billion. During the same period last year, the business earned $1.66 EPS. The firm’s revenue was up 4.1% compared to the same quarter last year. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. As a group, equities research analysts forecast that Amdocs will post 6.21 earnings per share for the current fiscal year.

Amdocs Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Tuesday, March 31st will be given a $0.569 dividend. This is a positive change from Amdocs’s previous quarterly dividend of $0.53. This represents a $2.28 annualized dividend and a dividend yield of 3.4%. The ex-dividend date of this dividend is Tuesday, March 31st. Amdocs’s dividend payout ratio (DPR) is currently 44.10%.

Hedge Funds Weigh In On Amdocs

A number of institutional investors and hedge funds have recently bought and sold shares of DOX. LSV Asset Management lifted its stake in shares of Amdocs by 7.6% in the third quarter. LSV Asset Management now owns 3,648,703 shares of the technology company’s stock valued at $299,376,000 after buying an additional 257,193 shares during the period. New York State Common Retirement Fund increased its stake in Amdocs by 20.3% during the third quarter. New York State Common Retirement Fund now owns 554,401 shares of the technology company’s stock valued at $45,489,000 after acquiring an additional 93,527 shares during the period. Illinois Municipal Retirement Fund raised its holdings in Amdocs by 46.6% in the 3rd quarter. Illinois Municipal Retirement Fund now owns 149,539 shares of the technology company’s stock valued at $12,270,000 after acquiring an additional 47,537 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in Amdocs by 13.6% in the 2nd quarter. JPMorgan Chase & Co. now owns 266,124 shares of the technology company’s stock valued at $24,281,000 after acquiring an additional 31,827 shares in the last quarter. Finally, Alps Advisors Inc. lifted its position in shares of Amdocs by 11.6% in the 3rd quarter. Alps Advisors Inc. now owns 237,883 shares of the technology company’s stock worth $19,518,000 after acquiring an additional 24,771 shares during the period. Institutional investors own 92.02% of the company’s stock.

Amdocs Company Profile

(Get Free Report)

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.

Read More

Analyst Recommendations for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.